Preferential CTL targeting of Gag is associated with relative viral control in long-term surviving HIV-1 infected former plasma donors from China

Cell Research

Volumn 22, Issue 5, 2012, Pages 903-914

  Jia, Mingming ^a   Hong, Kunxue ^a   Chen, Jianping ^a   Ruan, Yuhua ^a   Wang, Zhe ^b   Su, Bing ^c   Ren, Guoliang ^a   Zhang, Xiaoqing ^a   Liu, Zhen ^a   Zhao, Quanbi ^a   Li, Dan ^a   Peng, Hong ^a   Altfeld, Marcus ^d   Walker, Bruce D ^d   Yu, Xu G ^d   Shao, Yiming ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Anhui Center for Disease Control and Prevention   (China)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

cytotoxic T lymphocytes; Gag; human immunodeficiency virus type 1; human leukocyte antigen class I

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GAG PROTEIN; GAMMA INTERFERON; HLA A ANTIGEN; HLA A*30 ANTIGEN; HLA B*13:14 ANTIGEN; HLA B13 ANTIGEN; HLA C ANTIGEN; HLA C*06 ANTIGEN; HLA-A*30 ANTIGEN; HLA-B*13:14 ANTIGEN; HLA-C*06 ANTIGEN; PEPTIDE;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BLOOD DONOR; CD4 LYMPHOCYTE COUNT; CHEMISTRY; CHINA; COHORT ANALYSIS; CYTOTOXIC T LYMPHOCYTE; DRUG ANTAGONISM; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; VIROLOGY; VIRUS LOAD;

ADULT; AGED; AMINO ACID SEQUENCE; ANTI-HIV AGENTS; BLOOD DONORS; CD4 LYMPHOCYTE COUNT; CHINA; COHORT STUDIES; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HAPLOTYPES; HIV INFECTIONS; HIV-1; HLA-A ANTIGENS; HLA-B13 ANTIGEN; HLA-C ANTIGENS; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84862816102     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2012.19     Document Type: Article

References (45)

1. Carrington M, Bontrop RE. Effects of MHC class I on HIV/ SIV disease in primates. AIDS 2002; 16Suppl4:S105-S114.
2. Kawashima Y, Pfafferott K, Frater J, et al. Adaptation of HIV- 1 to human leukocyte antigen class I. Nature 2009; 458:641-645.
3. Carrington M, O'Brien SJ. The influence of HLA genotype on AIDS. Annu Rev Med 2003; 54:535-551.
4. Brumme ZL, Brumme CJ, Carlson J, et al. Marked epitopeand allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J Virol 2008; 82:9216-9227.
5. Riviere Y, McChesney MB, Porrot F, et al. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res Hum Retroviruses 1995; 11:903-907.
6. Zuniga R, Lucchetti A, Galvan P, et al. Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J Virol 2006; 80:3122-3125.
7. Borghans JA, Molgaard A, de Boer RJ, Kesmir C. HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24. PLoS One 2007; 2:e920.
8. Kiepiela P, Ngumbela K, Thobakgale C, et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2007; 13:46-53.
9. van Baalen CA, Guillon C, van Baalen M, et al. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes. Eur J Immunol 2002; 32:2644-2652.
10. Tenzer S, Wee E, Burgevin A, et al. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat Immunol 2009; 10:636-646.
11. Miura T, Brockman MA, Schneidewind A, et al. HLA-B57/ B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition. J Virol 2009; 83:2743-2755.
12. Schneidewind A, Brockman MA, Yang R, et al. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol 2007; 81:12382-12393.
13. Addo MM, Yu XG, Rathod A, et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)- specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 2003; 77:2081-2092.
14. Cao J, McNevin J, Holte S, Fink L, Corey L, McElrath MJ. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection. J Virol 2003; 77:6867-6878.
15. Betts MR, Ambrozak DR, Douek DC, et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J Virol 2001; 75:11983-11991.
16. Novitsky V, Gilbert P, Peter T, et al. Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J Virol 2003; 77:882-890.
17. Pereyra F, Addo MM, Kaufmann DE, et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis 2008; 197:563-571.
18. Kaufman J, Jing J. China and AIDS - the time to act is now. Science 2002; 296:2339-2340.
19. Zhang W, Hu D, Xi Y, Zhang M, Duan G. Spread of HIV in one village in central China with a high prevalence rate of blood-borne AIDS. Int J Infect Dis 2006; 10:475-480.
20. Su B, Liu L, Wang F, et al. HIV-1 subtype B' dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China. AIDS 2003; 17:2515-2520.
21. Zhang L, Chen Z, Cao Y, et al. Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in China. J Virol 2004; 78:13591-13599.
22. Frahm N, Korber BT, Adams CM, et al. Consistent cytotoxic- T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol 2004; 78:2187-2200.
23. Novitsky V, Cao H, Rybak N, et al. Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C. J Virol 2002; 76:10155-10168.
24. Briggs JA, Simon MN, Gross I, et al. The stoichiometry of Gag protein in HIV-1. Nat Struct Mol Biol 2004; 11:672-675.
25. Shehu-Xhilaga M, Crowe SM, Mak J. Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity. J Virol 2001; 75:1834-1841.
26. Sacha JB, Chung C, Rakasz EG, et al. Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression. J Immunol 2007; 178:2746-2754.
27. Edwards BH, Bansal A, Sabbaj S, Bakari J, Mulligan MJ, Goepfert PA. Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J Virol 2002; 76:2298-2305.
28. Ammaranond P, Zaunders J, Satchell C, van Bockel D, Cooper DA, Kelleher AD. A new variant cytotoxic T lymphocyte npg Cell Research | Vol 22 No 5 | May 2012 escape mutation in HLA-B27-positive individuals infected with HIV type 1. AIDS Res Hum Retroviruses 2005; 21:395-397.
29. Leslie AJ, Pfafferott KJ, Chetty P, et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004; 10:282-289.
30. Fernandez CS, Stratov I, De Rose R, et al. Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. J Virol 2005; 79:5721-5731.
31. Fernandez CS, Smith MZ, Batten CJ, et al. Vaccine-induced T cells control reversion of AIDS virus immune escape mutants. J Virol 2007; 81:4137-4144.
32. Wright JK, Novitsky V, Brockman MA, et al. Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C. J Virol 2011; 85:3996-4006.
33. Kaufmann DE, Walker BD. PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention. J Immunol 2009; 182:5891-5897.
34. Owen RE, Heitman JW, Hirschkorn DF, et al. HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses. AIDS 2010; 24:1095-1105.
35. Muthumani K, Hwang DS, Dayes NS, Kim JJ, Weiner DB. The HIV-1 accessory gene vpr can inhibit antigen-specific immune function. DNA Cell Biol 2002; 21:689-695.
36. Majumder B, Venkatachari NJ, Srinivasan A, Ayyavoo V. HIV-1 mediated immune pathogenesis: spotlight on the role of viral protein R (Vpr). Curr HIV Res 2009; 7:169-177.
37. Srinivasan A, Ayyavoo V, Mahalingam S, et al. A comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: potential impact on CTL epitopes. Virol J 2008; 5:99.
38. Saez-Cirion A, Lacabaratz C, Lambotte O, et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci USA 2007; 104:6776-6781.
39. Betts MR, Nason MC, West SM, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006; 107:4781-4789.
40. Emu B, Sinclair E, Hatano H, et al. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control. J Virol 2008; 82:5398-5407.
41. Yuan F, Sun YY, Luo Y, et al. Haplotype and linkage analysis of HLA-I classical genes in Chinese Han population. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2007; 15:1084-1089.
42. Harrer EG, Bergmann S, Eismann K, et al. A conserved HLA B13-restricted cytotoxic T lymphocyte epitope in Nef is a dominant epitope in HLA B13-positive HIV-1-infected patients. AIDS 2005; 19:734-735.
43. Tang J, Tang S, Lobashevsky E, et al. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. J Virol 2002; 76:8276-8284.
44. Honeyborne I, Prendergast A, Pereyra F, et al. Control of human immunodeficiency virus type 1 is associated with HLAB* 13 and targeting of multiple gag-specific CD8+ T-cell epitopes. J Virol 2007; 81:3667-3672.
45. Lichterfeld M, Yu XG, Cohen D, et al. HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity. AIDS 2004; 18:1383-1392.